April 2017: Prevention of type 2 diabetes - where do you draw the line?

In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss a national initiative to identify and manage people at high risk of developing type 2 diabetes. Full article available here: http://dtb.bmj.com/content/55/4/37. The editors also review the evidence for an HRT product containing bazedoxifene and conjugated oestrogens (http://dtb.bmj.com/content/55/4/42) and discuss a new formulation of lidocaine and prilocaine licensed for treatment of premature ejaculation (http://dtb.bmj.com/content/55/4/45). The highlights of the DTB April 2017's issue here:

http://dtb.bmj.com/content/55/4/38.